跳至主要内容
临床试验/JPRN-UMIN000046853
JPRN-UMIN000046853已完成未知

Investigation of hepatitis B virus reactivation after novel molecular targeted therapy with immunostimulatory effect (solid tumors) - Investigation of Hepatitis B Reactivation by Immune Checkpoint Inhibitors (Solid Tumors)

ational Institute for Medical Research and Development (AMED)0 个研究点目标入组 321 人开始时间: 2022年2月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
321

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (Common to Cohort 1 and Cohort 2) 1) Have indicated their intention not to participate in this study 2) Have been judged ineligible for this study by the principal investigator at each institution

研究者

发起方
ational Institute for Medical Research and Development (AMED)

相似试验

Investigation of hepatitis B virus reactivation... | 临床试验